Hydra Biosciences, Inc.

Closed

Cambridge, United States · Founded 2001 · $72.2M raised

Employees
11–50
Founded
2001
Business Model
B2B
Total Funding
$72.2M
Last Round
Series EMar 2015
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Hydra Biosciences was a biopharmaceutical company based in Cambridge, Massachusetts, that developed novel drugs to treat pain, inflammation, cardiovascular and other diseases using its expertise in ion channels. Its proprietary high-throughput screening platforms enabled the company to identify and develop drug candidates addressing significant unmet medical needs, and its intellectual property and ion-channel expertise set it apart from other biopharmaceutical companies before it wound down its operations.

Summary

Hydra Biosciences, Inc. is a Biotech company based in Cambridge, United States, founded in 2001. It has raised $72.2M in total across 5 rounds, most recently a Series E round in Mar 2015. Investors include MedImmune Ventures, Polaris Partners and Advanced Technology Ventures.

Funding History

Series ESeries EMar 2015

Sign up to see all 5 events

Funding: Series A through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
ArsenalBio

Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...

San Francisco, United States201–500Biotech, Life Sciences
Series CTotal funding$955.0MSep 2024
Lyell ImmunopharmaIPO

Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...

South San Francisco, United States201–500Biotech, Healthcare
Venture RoundTotal funding$884.0MJul 2025

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Hydra Biosciences, Inc. on Indexed.vc
<a href="https://indexed.vc/companies/hydra-biosciences-inc"><img src="https://indexed.vc/api/badge/company/hydra-biosciences-inc" alt="Hydra Biosciences, Inc. on Indexed.vc" width="260" height="76" /></a>